Safety is the highest priority when testing cosmetic products for children, and adherence to strict regulations and guidelines is essential. A widely recommended approach is to initially test products on adult volunteers to establish a baseline for safety before considering any tests involving children. This ensures that potential risks are thoroughly minimized, and any harmful effects are promptly identified.
For products specifically designed for children, such as diapers or baby wipes, safety evaluations can be performed using adult volunteers under highly controlled and exaggerated conditions, such as patch testing. To better mimic the characteristics of children's skin, it is strongly advised that a substantial portion of adult volunteers have sensitive skin.
Testing cosmetic products on children should strictly exclude high-risk ingredients due to their skin being far more delicate and sensitive than that of adults. This strategy allows manufacturers to preemptively identify and address potential risks, ensuring the product's safety for these most vulnerable users.
We offer several clinical safety testing solutions to verify product safety and substantiate related claims:
1. Primary dermal irritation test: Determines if the product will cause immediate irritation when applied to the skin. A small amount of the product is applied to a specific area of the skin, usually under a patch. The application site is then monitored for a short period for signs of redness, swelling or irritation.
Claims substantiated:
- Gentle on skin
- Non-irritating
- Non-irritating to sensitive skin
2. Cumulative irritation test: Evaluates whether repeated use of the product over time causes skin irritation. The product is applied repeatedly to the same skin area over several days to simulate regular use. The skin is then observed for signs of irritation, redness or damage.
Claims substantiated:
- Gentle on skin for repeated use
- Mild for long-term use
3. Human repeated induction patch test (HRIPT): Assesses whether a product may cause allergic reactions after repeated exposure. The product is applied to the skin multiple times over three weeks, followed by a rest period and a final challenge application. The skin is closely monitored for allergic responses like redness, swelling or rashes.
Claims substantiated:
- Non-inducer of allergic response
- Pediatrician reviewed
- Dermatologically tested for sensitive skin
4. Phototoxicity and photoallergy tests: Evaluate whether a product triggers adverse skin reactions when exposed to sunlight or UV radiation. The product is applied to the skin and exposed to UV light. The site is then observed for redness, rashes or swelling.
Claims substantiated:
- Non-photosensitizing
- Gentle on skin under sunlight
5. Ocular tear-free test: Determines if a product is gentle on the eyes and does not cause irritation or tears. The product is tested in vitro, using models that replicate eye tissue, and subsequently in vivo on human volunteers under controlled conditions. The eyes are monitored for irritation, redness or discomfort.
Claims substantiated:
- Tear-free
- Ophthalmologist tested
- Gentle for sensitive eyes
By conducting these rigorous safety evaluations, manufacturers and brands can ensure that their products meet the highest safety standards for adults and are well-prepared to undertake safety testing on children when necessary and appropriate.
About SGS
SGS is the world’s leading Testing, Inspection and Certification company. We operate a network of over 2,500 laboratories and business facilities across 115 countries, supported by a team of 99,500 dedicated professionals. With over 145 years of service excellence, we combine the precision and accuracy that define Swiss companies to help organizations achieve the highest standards of quality, compliance and sustainability.
Our brand promise – when you need to be sure – underscores our commitment to trust, integrity and reliability, enabling businesses to thrive with confidence. We proudly deliver our expert services through the SGS name and trusted specialized brands, including Brightsight, Bluesign, Maine Pointe and Nutrasource.
SGS is publicly traded on the SIX Swiss Exchange under the ticker symbol SGSN (ISIN CH1256740924, Reuters SGSN.S, Bloomberg SGSN:SW).
Av. Perú 809 e/ Herminio Giménez,
1224,
Asuncion, Paraguay